Also categorized in BoardNews:
TaskRabbit CEO Steps Down, Making Silicon Valley’s Diversity Outlook Bleak
x hide permanently

Starboard Gauges Bristol-Myers Shareholder Support for Celgene Deal

Stock Market Quotes and News

(Reuters) - Activist hedge fund Starboard Value LP has asked a proxy solicitor to probe the level of support among Bristol-Myers Squibb Co shareholders for the U.S. drug maker's $74 billion (57 billion pounds) deal to buy Celgene Corp, people familiar with the matter said on Friday. The acquisition would be the biggest pharmaceuticals deal ever and would unite two major sellers of cancer drugs. Starboard has not decided whether it would oppose the Celgene deal, the sources said...

Mentions: Hedge Fund acquisition Bristol-Myers Squibb